Charles River Laboratories has unloaded QS Pharma, a Philadelphia-area CDMO, months after picking it up as part of its $585 million buyout of WIL Research.

New Jersey-based CDMO Catalent grew its revenues in the second quarter but saw a significant fall in net earnings, but still beat analysts forecasts. It has…

Sun Pharma is said to be shopping its Ohm Laboratories plants in New Jersey as part of a manufacturing consolidation.

With its $830 million deal to buy Dendreon, Chinese conglomerate Sanpower Group takes on the expensive process of manufacturing prostate cancer vaccine…

India’s Aurobindo Pharma, which has been building its presence around the world, has struck a new deal to buy a generics manufacturer and plant in Portugal…

Swiss CMO Lonza, which has been searching for a game-changing M&A deal, looks to have unearthed one in contractor Capsugel.

Sanofi recently that it will sell off its generic drug unit in Europe, a decision that will affect two manufacturing plants in the Czech Republic and Romania.

A surplus Eli Lilly plant in Puerto Rico has a new owner, which intends to invest more than $90 million in upgrades and hire 350 workers.

M&A